- Home
- ALZN vs CARV Comparison
ALZN vs CARV Comparison
Compare ALZN & CARV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALZN
- CARV
- Stock Information
- Founded
- ALZN 2016
- CARV 1948
- Country
- ALZN United States
- CARV United States
- Employees
- ALZN N/A
- CARV N/A
- Industry
- ALZN Medicinal Chemicals and Botanical Products
- CARV Savings Institutions
- Sector
- ALZN Health Care
- CARV Finance
- Exchange
- ALZN Nasdaq
- CARV Nasdaq
- Market Cap
- ALZN 6.1M
- CARV 7.2M
- IPO Year
- ALZN 2021
- CARV 1994
- Fundamental
- Price
- ALZN $0.70
- CARV $1.36
- Analyst Decision
- ALZN Strong Buy
- CARV
- Analyst Count
- ALZN 1
- CARV 0
- Target Price
- ALZN $20.00
- CARV N/A
- AVG Volume (30 Days)
- ALZN 124.9K
- CARV 9.2K
- Earning Date
- ALZN 03-10-2025
- CARV 02-13-2025
- Dividend Yield
- ALZN N/A
- CARV N/A
- EPS Growth
- ALZN N/A
- CARV N/A
- EPS
- ALZN N/A
- CARV N/A
- Revenue
- ALZN N/A
- CARV $24,056,000.00
- Revenue This Year
- ALZN $322.64
- CARV N/A
- Revenue Next Year
- ALZN N/A
- CARV N/A
- P/E Ratio
- ALZN N/A
- CARV N/A
- Revenue Growth
- ALZN N/A
- CARV N/A
- 52 Week Low
- ALZN $0.64
- CARV $1.30
- 52 Week High
- ALZN $15.06
- CARV $2.39
- Technical
- Relative Strength Index (RSI)
- ALZN 35.54
- CARV 43.47
- Support Level
- ALZN $0.67
- CARV $1.31
- Resistance Level
- ALZN $0.71
- CARV $1.39
- Average True Range (ATR)
- ALZN 0.07
- CARV 0.07
- MACD
- ALZN -0.02
- CARV 0.00
- Stochastic Oscillator
- ALZN 10.43
- CARV 28.95
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
About CARV Carver Bancorp Inc.
Carver Bancorp Inc is a holding company and conducts its business as a unitary saving and loan holding firm and the business of the company consists of the operation of its subsidiary. The bank offers a wide range of financial solutions to meet customers' banking. It offers other consumer and commercial banking products and services, such as debit cards, online banking, online bill pay, and telephone banking. The company provides deposit products, such as demand, savings, and time deposits for consumers, businesses, and governmental and quasi-governmental agencies in its market area within New York City.